Interstitial pneumonitis associated with dasatinib treatment for chronic myeloid leukemia or acute lymphoblastic leukemia: case series and a literature review

Dasatinib, a tyrosine kinase inhibitor, is usually prescribed for chronic myeloid leukemia and Philadelphia chromosome–positive acute lymphoblastic leukemia. However, some patients may develop an intolerance to this drug over the years. Among various toxicities related to dasatinib, dasatinib-associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sang-A, Kwon, Byoung Soo, Chung, Jin-Haeng, Lee, Ji Yun, Bang, Soo-Mee, Lee, Jeong-Ok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647296/
https://www.ncbi.nlm.nih.gov/pubmed/36346055
http://dx.doi.org/10.1177/17534666221135322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647296/
https://www.ncbi.nlm.nih.gov/pubmed/36346055
http://dx.doi.org/10.1177/17534666221135322

Ejemplares similares